These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17114428)

  • 21. Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells.
    Roberts SA; Barbour G; Matarrese MR; Mason DL; Leiter EH; Haskins K; Hanson MS
    J Autoimmun; 2003 Sep; 21(2):139-47. PubMed ID: 12935783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of effectors and regulators are decisive in the manifestations of type 1 diabetes in nonobese diabetic mice.
    Quinn A; Kumar V; Jensen KP; Sercarz EE
    Curr Dir Autoimmun; 2001; 4():171-92. PubMed ID: 11569402
    [No Abstract]   [Full Text] [Related]  

  • 23. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.
    Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST
    Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice.
    Mellanby RJ; Phillips JM; Parish NM; Cooke A
    Autoimmunity; 2008 Aug; 41(5):383-94. PubMed ID: 18568644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
    Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
    J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.
    Hess AD; Thoburn CJ
    Biol Blood Marrow Transplant; 2006 May; 12(5):518-29. PubMed ID: 16635787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
    Manirarora JN; Wei CH
    J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymic development of autoreactive T cells in NOD mice is regulated in an age-dependent manner.
    He Q; Morillon YM; Spidale NA; Kroger CJ; Liu B; Sartor RB; Wang B; Tisch R
    J Immunol; 2013 Dec; 191(12):5858-66. PubMed ID: 24198282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.
    Esensten JH; Lee MR; Glimcher LH; Bluestone JA
    J Immunol; 2009 Jul; 183(1):75-82. PubMed ID: 19535634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
    Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
    J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies and CD4 T cells target a beta cell retroviral envelope protein in non-obese diabetic mice.
    Levisetti MG; Suri A; Vidavsky I; Gross ML; Kanagawa O; Unanue ER
    Int Immunol; 2003 Dec; 15(12):1473-83. PubMed ID: 14645156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
    Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
    J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.
    Waid DM; Vaitaitis GM; Pennock ND; Wagner DH
    J Leukoc Biol; 2008 Aug; 84(2):431-9. PubMed ID: 18469093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
    Mora C; Wong FS; Chang CH; Flavell RA
    J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells.
    Lee MH; Lee WH; Todorov I; Liu CP
    J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
    Ly D; Mi QS; Hussain S; Delovitch TL
    J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.